IP Library › Granted Patent US 10,106,541
Granted Patent B2
US 10,106,541 · App. 15/846,757 · Granted Oct 23, 2018

Intermediates for preparing CGRP receptor antagonists

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 10,106,541
App. No.
15/846,757
Granted
Oct 23, 2018
Kind
B2
Abstract

The invention encompasses a novel process for making piperidinone carboxamide indane and azainane derivatives, which are CGRP receptor antagonists useful for the treatment of migraine.

Claims (5)

1. A compound selected from:

2. The compound according to claim 1 , wherein the compound is:

3. The compound according to claim 1 , wherein the compound is:

4. The compound according to claim 1 , wherein the compound is:

5. The compound according to claim 1 , wherein the compound is:

Assignments (1)
MERGER Recorded Aug 8, 2022
From: MERCK SHARP & DOHME CORP.
To: MERCK SHARP & DOHME LLC
Reel/Frame 061102/0145 →
Cited By (7)
US 12,350,259 US 12,383,545 US 12,458,632 US 12,458,633 US 12,465,598 US 12,622,897 US 12,661,341